Research and Markets: Elekta Medical Device Company Intelligence Report - Order Now

DUBLIN--(Business Wire)--
Research and Markets
(http://www.researchandmarkets.com/research/7e1de4/elekta_medical_dev) has
announced the addition of the "Elekta Medical Device Company Intelligence
Report" company profile to their offering.

Elekta AB, headquartered in Stockholm, Sweden, offers clinical solutions and
services for the radiation treatment of cancer and the minimally-invasive
treatment of brain disorders, including tumours, vascular disorders and
functional disorders such as facial pain, epilepsy and Parkinson's disease. In
fiscal 2005, Elekta's revenue rose by 9% to SKr 3.2 billion.

Elekta operates within two business areas, oncology and neurosurgery. The
company's main business is oncology, sales of which increased by 16% to SKr 2.2
billion in 2005. Elekta claims to be the world's second-largest supplier of
oncology products after Varian Medical Systems. It offers linear accelerators,
simulators, stereotactic radiotherapy equipment, 3D dose planning systems and
products for intensity-modulated radiation treatment. In April 2005, Elekta
acquired Impac Medical Systems, enabling Elekta to also offer a range of medical
IT systems for use in cancer care, including integrated solutions centred on
image-enabled electronic medical records covering the cancer treatment process.

Elekta claims to be the market leader for devices for the radiosurgical
treatment of brain disorders as a result of its Leksell Gamma Knife technology.
The company's neurosurgery products also include the magnetoencephalography
devices gained through the 2003 acquisition of Neuromag. In 2005, neurosurgery
sales declined by 5% to SKr 977 million.

Executive Summary:

Medical Device Company Intelligence Reports provide a full review of the
company's activities, from its origins to its latest corporate activity,
including mergers and acquisitions, agreements, divestitures, major purchasing
contracts and litigation. Sections are included on products, international
activities and R&D, as well as a full, in-depth five year financial analysis. An
introduction to each report and a full table of contents is provided for review.
More than 60 Medical Device Company Intelligence Reports are currently
available.

Key Topics Covered:

1.Overview

2.Corporate History

3.Products

4.International Activities

5.Research And Development

6.Financial Review

For more information visit
http://www.researchandmarkets.com/research/7e1de4/elekta_medical_dev

Source: Espicom Business Intelligence Ltd

Laura Wood
Senior Manager
press@researchandmarkets.com
Fax from USA: 646-607-1907
Fax from rest of the world: +353-1-481-1716

Copyright Business Wire 2009